April 16, 2026
United States Securities and Exchange Commission
Division of Corporation Finance
Attn: Tyler Howes
100 F Street, N.E.
Washington, DC 20549
| Re: | Propanc Biopharma, Inc. | |
| Registration Statement on Form S-1 | ||
| Filed April 10, 2026 | ||
| File No. 333-295002 |
Ladies and Gentlemen:
The undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on April 20, 2026 at 12:00 p.m. Eastern Daylight Time, or as soon thereafter as practicable.
The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.
Very truly yours,
| Propanc Biopharma, Inc. | |
| /s/ James Nathanilesz | |
| James Nathanilesz | |
| Chief Executive Officer |